Alyeska Investment Group »

Silverback Therapeutics shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.9M 390k 10.05
2025-06-30 $5.1M 290k 17.45
2025-03-31 $3.6M 290k 12.58
2024-12-31 $13M 1.3M 10.55
2024-09-30 $1.8M 125k 14.50
2021-03-31 $1.1M 25k 43.64
2020-12-31 $1.2M 25k 46.36